Skip to main content

Table 1 Patient overview in all 78 patients

From: High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection

Factors

All patients (n = 78)

Age (y.o.)

69 (39–87)

Gender (Male / Female)

47 / 31

Neoadjuvant therapy

36

 Chemotherapy

25

 Chemoradiotherapy

11

PTPE

18

Type of liver resectiona

 No liver resection (PD, Extra bile duct resection)

5

 S1,5,6,7,8

27

 S1,4,5,6,7,8

7

 S1,2,3,4

26

 S1,2,3,4,5,8

5

 Others

8

Histological type: G1 / G2 / G3 / others

49 / 18 / 9 / 2

TNM (UICC 8th)

 pT: T0 / T1 / T2 / T3 / T4

1 / 8 / 33 / 12 / 24

 pN: N0 / N1 or N2

40 / 38

 M1 (Intrahepatic / Extrahepatic)

6 (3 / 3)

Residual tumor status: R0 / R1 / R2

53 / 14 / 11

Postoperative hospital stay (median: days)

45.5 (13–325)

Complication ≥ C-D grade III

32

Postoperative chemotherapy

56

  1. PTPE percutaneous transhepatic portal vein embolization, PD pancreaticoduodenectomy, C-D Clavien-Dindo
  2. aExpressed as Couinaud’s hepatic segments resected